Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lübbert M, Rummelt C, Bertz H, Wäsch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M, Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rösler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C, Spyridonidis A, Stölzel F, Ordemann R, Müller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kröger N, Ayuk F, Vago L, Ciceri F, Müller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dörfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Börries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A, McLornan D, Mufti G, Oran B, Rezvani K, Shah O, Negrin RS, Nagler A, Prinz M, Burchert A, Neubauer A, Beelen D, Mackensen A, von Bubnoff N, Herr W, Becher B, Socié G, Caligiuri MA, Ruggiero E, Bonini C, Häcker G, Duyster J, Finke J, Pearce E, Blazar BR, Zeiser R

Open source

DOI: 10.1038/nm.4484
Published: 2018 Mar
Container: Nature medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/nm.4484,
  title = {Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.},
  author = {Mathew NR and Baumgartner F and Braun L and O'Sullivan D and Thomas S and Waterhouse M and Müller TA and Hanke K and Taromi S and Apostolova P and Illert AL and Melchinger W and Duquesne S and Schmitt-Graeff A and Osswald L and Yan KL and Weber A and Tugues S and Spath S and Pfeifer D and Follo M and Claus R and Lübbert M and Rummelt C and Bertz H and Wäsch R and Haag J and Schmidts A and Schultheiss M and Bettinger D and Thimme R and Ullrich E and Tanriver Y and Vuong GL and Arnold R and Hemmati P and Wolf D and Ditschkowski M and Jilg C and Wilhelm K and Leiber C and Gerull S and Halter J and Lengerke C and Pabst T and Schroeder T and Kobbe G and Rösler W and Doostkam S and Meckel S and Stabla K and Metzelder SK and Halbach S and Brummer T and Hu Z and Dengjel J and Hackanson B and Schmid C and Holtick U and Scheid C and Spyridonidis A and Stölzel F and Ordemann R and Müller LP and Sicre-de-Fontbrune F and Ihorst G and Kuball J and Ehlert JE and Feger D and Wagner EM and Cahn JY and Schnell J and Kuchenbauer F and Bunjes D and Chakraverty R and Richardson S and Gill S and Kröger N and Ayuk F and Vago L and Ciceri F and Müller AM and Kondo T and Teshima T and Klaeger S and Kuster B and Kim DDH and Weisdorf D and van der Velden W and Dörfel D and Bethge W and Hilgendorf I and Hochhaus A and Andrieux G and Börries M and Busch H and Magenau J and Reddy P and Labopin M and Antin JH and Henden AS and Hill GR and Kennedy GA and Bar M and Sarma A and McLornan D and Mufti G and Oran B and Rezvani K and Shah O and Negrin RS and Nagler A and Prinz M and Burchert A and Neubauer A and Beelen D and Mackensen A and von Bubnoff N and Herr W and Becher B and Socié G and Caligiuri MA and Ruggiero E and Bonini C and Häcker G and Duyster J and Finke J and Pearce E and Blazar BR and Zeiser R},
  year = {2018},
  journal = {Nature medicine},
  doi = {10.1038/nm.4484},
  url = {https://doi.org/10.1038/nm.4484}
}

RIS

TY  - JOUR
TI  - Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
AU  - Mathew NR
AU  - Baumgartner F
AU  - Braun L
AU  - O'Sullivan D
AU  - Thomas S
AU  - Waterhouse M
AU  - Müller TA
AU  - Hanke K
AU  - Taromi S
AU  - Apostolova P
AU  - Illert AL
AU  - Melchinger W
AU  - Duquesne S
AU  - Schmitt-Graeff A
AU  - Osswald L
AU  - Yan KL
AU  - Weber A
AU  - Tugues S
AU  - Spath S
AU  - Pfeifer D
AU  - Follo M
AU  - Claus R
AU  - Lübbert M
AU  - Rummelt C
AU  - Bertz H
AU  - Wäsch R
AU  - Haag J
AU  - Schmidts A
AU  - Schultheiss M
AU  - Bettinger D
AU  - Thimme R
AU  - Ullrich E
AU  - Tanriver Y
AU  - Vuong GL
AU  - Arnold R
AU  - Hemmati P
AU  - Wolf D
AU  - Ditschkowski M
AU  - Jilg C
AU  - Wilhelm K
AU  - Leiber C
AU  - Gerull S
AU  - Halter J
AU  - Lengerke C
AU  - Pabst T
AU  - Schroeder T
AU  - Kobbe G
AU  - Rösler W
AU  - Doostkam S
AU  - Meckel S
AU  - Stabla K
AU  - Metzelder SK
AU  - Halbach S
AU  - Brummer T
AU  - Hu Z
AU  - Dengjel J
AU  - Hackanson B
AU  - Schmid C
AU  - Holtick U
AU  - Scheid C
AU  - Spyridonidis A
AU  - Stölzel F
AU  - Ordemann R
AU  - Müller LP
AU  - Sicre-de-Fontbrune F
AU  - Ihorst G
AU  - Kuball J
AU  - Ehlert JE
AU  - Feger D
AU  - Wagner EM
AU  - Cahn JY
AU  - Schnell J
AU  - Kuchenbauer F
AU  - Bunjes D
AU  - Chakraverty R
AU  - Richardson S
AU  - Gill S
AU  - Kröger N
AU  - Ayuk F
AU  - Vago L
AU  - Ciceri F
AU  - Müller AM
AU  - Kondo T
AU  - Teshima T
AU  - Klaeger S
AU  - Kuster B
AU  - Kim DDH
AU  - Weisdorf D
AU  - van der Velden W
AU  - Dörfel D
AU  - Bethge W
AU  - Hilgendorf I
AU  - Hochhaus A
AU  - Andrieux G
AU  - Börries M
AU  - Busch H
AU  - Magenau J
AU  - Reddy P
AU  - Labopin M
AU  - Antin JH
AU  - Henden AS
AU  - Hill GR
AU  - Kennedy GA
AU  - Bar M
AU  - Sarma A
AU  - McLornan D
AU  - Mufti G
AU  - Oran B
AU  - Rezvani K
AU  - Shah O
AU  - Negrin RS
AU  - Nagler A
AU  - Prinz M
AU  - Burchert A
AU  - Neubauer A
AU  - Beelen D
AU  - Mackensen A
AU  - von Bubnoff N
AU  - Herr W
AU  - Becher B
AU  - Socié G
AU  - Caligiuri MA
AU  - Ruggiero E
AU  - Bonini C
AU  - Häcker G
AU  - Duyster J
AU  - Finke J
AU  - Pearce E
AU  - Blazar BR
AU  - Zeiser R
PY  - 2018
JO  - Nature medicine
DO  - 10.1038/nm.4484
UR  - https://doi.org/10.1038/nm.4484
ER  -

APA

NR, M., F, B., L, B., D, O., S, T., M, W., TA, M., K, H., S, T., P, A., AL, I., W, M., S, D., A, S., L, O., KL, Y., A, W., S, T., S, S., D, P., M, F., R, C., M, L., C, R., H, B., R, W., J, H., A, S., M, S., D, B., R, T., E, U., Y, T., GL, V., R, A., P, H., D, W., M, D., C, J., K, W., C, L., S, G., J, H., C, L., T, P., T, S., G, K., W, R., S, D., S, M., K, S., SK, M., S, H., T, B., Z, H., J, D., B, H., C, S., U, H., C, S., A, S., F, S., R, O., LP, M., F, S., G, I., J, K., JE, E., D, F., EM, W., JY, C., J, S., F, K., D, B., R, C., S, R., S, G., N, K., F, A., L, V., F, C., AM, M., T, K., T, T., S, K., B, K., DDH, K., D, W., W, V. D. V., D, D., W, B., I, H., A, H., G, A., M, B., H, B., J, M., P, R., M, L., JH, A., AS, H., GR, H., GA, K., M, B., A, S., D, M., G, M., B, O., K, R., O, S., RS, N., A, N., M, P., A, B., A, N., D, B., A, M., N, V. B., W, H., B, B., G, S., MA, C., E, R., C, B., G, H., J, D., J, F., E, P., BR, B., & R, Z. (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.. Nature medicine. https://doi.org/10.1038/nm.4484

Source records

pubmed · retrieved 2026-09-26T09:34:34.100Z